财经FTC与多州指控Shkreli违反终身制药业禁令CNBC 等 3 家·2天前C美国联邦贸易委员会与多州提起藐视法庭申诉，称Martin Shkreli违反其终身不得涉足制药业的禁令。他此前因策划Daraprim垄断计划被定罪。阅读原文 · CNBC（在新窗口打开）另有 2 家媒体报道MarketWatch‘Pharma Bro’ Martin Shkreli is in trouble with regulators again, this time for influencing biopharma stocks（在新窗口打开）The GuardianFTC and seven states seek contempt ruling against Shkreli over pharma ban（在新窗口打开）
